Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Terminated3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03071744Phase 2Terminated
Lazanda in Cancer Patients Receiving Palliative Radiation
Bone Metastases
PrincipalinvestigatorStart date: 2017-03-01
NCT02745353Phase 2Terminated
Naloxegol in Cancer Opioid-Induced Constipation
Constipation
PrincipalinvestigatorStart date: 2016-05-01
NCT03008213Phase 2Terminated
Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV
Chemotherapy Induced Nausea Vomiting
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03071744Phase 2PrincipalInvestigator

Lazanda in Cancer Patients Receiving Palliative Radiation

Bone Metastases
Terminated
NCT02745353Phase 2PrincipalInvestigator

Naloxegol in Cancer Opioid-Induced Constipation

Constipation
Terminated
NCT03008213Phase 2PrincipalInvestigator

Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV

Chemotherapy Induced Nausea Vomiting
Terminated

All 3 trials loaded